Kim WJ - Search Results

1

Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1.

Kim IY, Lee DH, Lee DK, Kim WJ, Kim MM, Morton RA, Lerner SP, Kim SJ. Kim IY, et al. Among authors: kim mm, kim wj, kim sj. Cancer Res. 2004 Oct 15;64(20):7355-60. doi: 10.1158/0008-5472.CAN-04-0154. Cancer Res. 2004. PMID: 15492256

2

HMOX1 is an important prognostic indicator of nonmuscle invasive bladder cancer recurrence and progression.

Yim MS, Ha YS, Kim IY, Yun SJ, Choi YH, Kim WJ. Yim MS, et al. Among authors: kim iy, kim wj. J Urol. 2011 Feb;185(2):701-5. doi: 10.1016/j.juro.2010.09.081. Epub 2010 Dec 18. J Urol. 2011. PMID: 21168882

3

Tissue hOGG1 genotype predicts bladder cancer prognosis: a novel approach using a peptide nucleic acid clamping method.

Ha YS, Yan C, Kim IY, Yun SJ, Moon SK, Kim WJ. Ha YS, et al. Among authors: kim iy, kim wj. Ann Surg Oncol. 2011 Jun;18(6):1775-81. doi: 10.1245/s10434-010-1500-7. Epub 2010 Dec 24. Ann Surg Oncol. 2011. PMID: 21184188

4

Identification of C16orf74 as a marker of progression in primary non-muscle invasive bladder cancer.

Kim WT, Yun SJ, Park C, Kim IY, Moon SK, Kwon TG, Choi YH, Kim WJ. Kim WT, et al. Among authors: kim iy, kim wj. PLoS One. 2010 Dec 21;5(12):e15260. doi: 10.1371/journal.pone.0015260. PLoS One. 2010. PMID: 21203532 Free PMC article.

5

GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer.

Ha YS, Yan C, Jeong P, Kim WT, Yun SJ, Kim IY, Moon SK, Kim WJ. Ha YS, et al. Among authors: kim iy, kim wj, kim wt. J Korean Med Sci. 2011 Feb;26(2):231-6. doi: 10.3346/jkms.2011.26.2.231. Epub 2011 Jan 24. J Korean Med Sci. 2011. PMID: 21286014 Free PMC article.

6

A four-gene signature predicts disease progression in muscle invasive bladder cancer.

Kim WJ, Kim SK, Jeong P, Yun SJ, Cho IC, Kim IY, Moon SK, Um HD, Choi YH. Kim WJ, et al. Among authors: kim iy, kim sk. Mol Med. 2011 May-Jun;17(5-6):478-85. doi: 10.2119/molmed.2010.00274. Epub 2011 Feb 4. Mol Med. 2011. PMID: 21308147 Free PMC article.

7

Macrophages induce neuroendocrine differentiation of prostate cancer cells via BMP6-IL6 Loop.

Lee GT, Kwon SJ, Lee JH, Jeon SS, Jang KT, Choi HY, Lee HM, Kim WJ, Lee DH, Kim IY. Lee GT, et al. Among authors: kim iy, kim wj. Prostate. 2011 Oct 1;71(14):1525-37. doi: 10.1002/pros.21369. Epub 2011 Mar 3. Prostate. 2011. PMID: 21374653

8

Pathologic implications of prostatic anterior fat pad.

Jeong J, Choi EY, Kang DI, Ercolani M, Lee DH, Kim WJ, Kim IY. Jeong J, et al. Among authors: kim iy, kim wj. Urol Oncol. 2013 Jan;31(1):63-7. doi: 10.1016/j.urolonc.2010.09.003. Epub 2011 Mar 10. Urol Oncol. 2013. PMID: 21396837

9

Bone morphogenetic protein 6-induced interleukin-1β expression in macrophages requires PU.1/Smad1 interaction.

Lee GT, Jung YS, Lee JH, Kim WJ, Kim IY. Lee GT, et al. Among authors: kim iy, kim wj. Mol Immunol. 2011 Jul;48(12-13):1540-7. doi: 10.1016/j.molimm.2011.04.019. Epub 2011 May 14. Mol Immunol. 2011. PMID: 21571370

10

EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling.

Kim YJ, Yoon HY, Kim SK, Kim YW, Kim EJ, Kim IY, Kim WJ. Kim YJ, et al. Among authors: kim iy, kim wj, kim ej, kim sk, kim yw. Clin Cancer Res. 2011 Jul 1;17(13):4523-30. doi: 10.1158/1078-0432.CCR-10-2817. Epub 2011 May 13. Clin Cancer Res. 2011. PMID: 21571867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,109 results

Search Page

Filters